126 related articles for article (PubMed ID: 25402870)
1. Nox-4 and progressive kidney disease.
Thallas-Bonke V; Jandeleit-Dahm KA; Cooper ME
Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):74-80. PubMed ID: 25402870
[TBL] [Abstract][Full Text] [Related]
2. NADPH oxidase 5 and renal disease.
Holterman CE; Thibodeau JF; Kennedy CR
Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):81-7. PubMed ID: 25415612
[TBL] [Abstract][Full Text] [Related]
3. NADPH oxidase: A membrane-bound enzyme and its inhibitors in diabetic complications.
Laddha AP; Kulkarni YA
Eur J Pharmacol; 2020 Aug; 881():173206. PubMed ID: 32442539
[TBL] [Abstract][Full Text] [Related]
4. Nox and renal disease.
Holterman CE; Read NC; Kennedy CR
Clin Sci (Lond); 2015 Apr; 128(8):465-81. PubMed ID: 25630236
[TBL] [Abstract][Full Text] [Related]
5. NADPH oxidases in the kidney.
Gill PS; Wilcox CS
Antioxid Redox Signal; 2006; 8(9-10):1597-607. PubMed ID: 16987014
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases.
Sedeek M; Hébert RL; Kennedy CR; Burns KD; Touyz RM
Curr Opin Nephrol Hypertens; 2009 Mar; 18(2):122-7. PubMed ID: 19430333
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and advanced glycation in diabetic nephropathy.
Coughlan MT; Mibus AL; Forbes JM
Ann N Y Acad Sci; 2008 Apr; 1126():190-3. PubMed ID: 18448815
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy.
Wilkinson-Berka JL; Rana I; Armani R; Agrotis A
Clin Sci (Lond); 2013 May; 124(10):597-615. PubMed ID: 23379642
[TBL] [Abstract][Full Text] [Related]
10. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
[TBL] [Abstract][Full Text] [Related]
11. Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy.
Lambeth JD
Free Radic Biol Med; 2007 Aug; 43(3):332-47. PubMed ID: 17602948
[TBL] [Abstract][Full Text] [Related]
12. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
Paravicini TM; Touyz RM
Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
[TBL] [Abstract][Full Text] [Related]
13. Differential vascular functions of Nox family NADPH oxidases.
Brandes RP; Schröder K
Curr Opin Lipidol; 2008 Oct; 19(5):513-8. PubMed ID: 18769233
[TBL] [Abstract][Full Text] [Related]
14. Normalizing NADPH oxidase contributes to attenuating diabetic nephropathy by the dual endothelin receptor antagonist CPU0213 in rats.
Xu M; Dai DZ; Dai Y
Am J Nephrol; 2009; 29(3):252-6. PubMed ID: 18802327
[TBL] [Abstract][Full Text] [Related]
15. Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy.
Eid S; Abou-Kheir W; Sabra R; Daoud G; Jaffa A; Ziyadeh FN; Roman L; Eid AA
J Biol Regul Homeost Agents; 2013; 27(3):693-703. PubMed ID: 24152838
[TBL] [Abstract][Full Text] [Related]
16. NOX isoforms and reactive oxygen species in vascular health.
Touyz RM; Briones AM; Sedeek M; Burger D; Montezano AC
Mol Interv; 2011 Feb; 11(1):27-35. PubMed ID: 21441119
[TBL] [Abstract][Full Text] [Related]
17. NOXious signaling in pain processing.
Kallenborn-Gerhardt W; Schröder K; Geisslinger G; Schmidtko A
Pharmacol Ther; 2013 Mar; 137(3):309-17. PubMed ID: 23146925
[TBL] [Abstract][Full Text] [Related]
18. The signaling pathway of NADPH oxidase and its role in glomerular diseases.
Mao S; Huang S
J Recept Signal Transduct Res; 2014 Feb; 34(1):6-11. PubMed ID: 24156279
[TBL] [Abstract][Full Text] [Related]
19. The NADPH oxidase family and its inhibitors.
Kleniewska P; Piechota A; Skibska B; Gorąca A
Arch Immunol Ther Exp (Warsz); 2012 Aug; 60(4):277-94. PubMed ID: 22696046
[TBL] [Abstract][Full Text] [Related]
20. Complement-dependent NADPH oxidase enzyme activation in renal ischemia/reperfusion injury.
Simone S; Rascio F; Castellano G; Divella C; Chieti A; Ditonno P; Battaglia M; Crovace A; Staffieri F; Oortwijn B; Stallone G; Gesualdo L; Pertosa G; Grandaliano G
Free Radic Biol Med; 2014 Sep; 74():263-73. PubMed ID: 25017967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
